Should race be considered in diagnosing giant cell arteritis? - Authors' reply.

Autor: Gill T; Department of Rheumatology, London Northwest Hospitals NHS Trust, London, UK., Putman M; Department of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, USA., Sattui SE; Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA., Hamdulay S; Department of Rheumatology, London Northwest Hospitals NHS Trust, London, UK., Conway R; Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; Department of Rheumatology, St James's Hospital, Dublin, Ireland., Liew DFL; Department of Rheumatology and Department of Clinical Pharmacology and Therapeutics, Austin Health, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia., Sharma A; Clinical Immunology and Rheumatology Wing, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Stone JH; Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, USA., Mackie SL; Chapel Allerton Hospital, Leeds, UK; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Mehta P; Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London WC1E 6JF, UK; Department of Rheumatology, University College London Hospital NHS Trust, London, UK. Electronic address: puja.mehta@ucl.ac.uk.
Jazyk: angličtina
Zdroj: The Lancet. Rheumatology [Lancet Rheumatol] 2023 Jul; Vol. 5 (7), pp. e372-e373.
DOI: 10.1016/S2665-9913(23)00156-X
Abstrakt: Competing Interests: Author declarations remain the same as in the original Comment.
Databáze: MEDLINE